The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Depth of response and progression-free survival in patients with advanced ALK-positive non–small-cell lung cancer treated with lorlatinib.
 
Rosario Campelo
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Lilly; MSD; Pfizer; Roche; Sanofi; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Lilly; MSD; Pfizer; Roche; Sanofi; Takeda
Speakers' Bureau - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Lilly; MSD; Pfizer; Roche; Sanofi; Takeda
Research Funding - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Lilly; MSD; Pfizer; Roche; Sanofi; Takeda
 
Christian Schulz
Consulting or Advisory Role - AstraZeneca; BMS GmbH & Co. KG; Boehringer Ingelheim; MSD; Pfizer; Roche; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Lilly; MSD; Pfizer; Roche; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Roche
 
Young Joo Min
No Relationships to Disclose
 
Adnan Aydiner
No Relationships to Disclose
 
Maen Hussein
Consulting or Advisory Role - Abbvie; Aptitude Health; Aptitude Health; Aptitude Health; AstraZeneca; AstraZeneca; AstraZeneca; Athenex; AVEO; BeiGene; BMS; BMS; Coherus Biosciences; CTI BioPharma Corp; CTI BioPharma Corp; Exelixis; G1 Therapeutics; IntegraConnect; IntegraConnect; IntrinsiQ; ipsen; Karyopharm Therapeutics; Karyopharm Therapeutics; Karyopharm Therapeutics; Mirati Therapeutics; National Community Oncology Dispensing Association (NCODA); oncocyte
 
Alessandra di Pietro
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Honoraria - Pfizer
 
Anna Polli
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Jean-Francois Martini
Employment - Pfizer
Stock and Other Ownership Interests - Kiara Therapeutics; Pfizer
 
Hye Ryun Kim
Honoraria - AstraZeneca; MSD Oncology
Consulting or Advisory Role - AstraZeneca; BeiGene
Speakers' Bureau - ABL Bio; AstraZeneca; MSD Oncology; Ono Pharmaceutical; Roche/Genentech; Yuhan
Research Funding - AstraZeneca (Inst); Yuhan (Inst)